Leaderboards/Cardiac tumors and thrombi

Cardiac tumors and thrombi

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Yogi Andrew Taruk Padang
Unknown
2
Chirag A. Buch
The University of Texas at San Antonio Health Science Center
3
Yuqing Shi
Changchun University of Chinese Medicine
4
Jakoba J. Eertink
Amsterdam Neuroscience
5
Zhongfan Zhang
Jilin University
6
Jessica Burns
Institute of Cancer Research
7
Xiaorui Ping
Nankai University
8
Fleur H.J. Kaptein
Leiden University Medical Center
9
Alief Waitupu
Airlangga University
10
Megan E. Bass
University of Colorado Hospital

Papers

1
Giant Left Atrial Myxoma Revealed by Neurological Manifestation in a Young Female Patient
International Journal of Innovative Science and Research Technology (IJISRT)|2024
242 cit.
2
Cholesterol crystal embolism: Unraveling its impact on atherosclerotic cardiovascular diseases
Journal of Medicine Surgery and Public Health|2024
5 cit.
3
The development process of ‘fit-for-purpose’ imaging biomarkers to characterize the tumor microenvironment
Frontiers in Medicine|2024
5 cit.
4
Publication in Thrombosis Research (2024) [5 citations, W4400026473]
Thrombosis Research|2024
5 cit.
5
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response
Haematologica|2025
1 cit.
6
Publication in New England Journal of Medicine (2025) [W4409987440]
New England Journal of Medicine|2025
0 cit.
7
Publication (2025) [W4412549030]
Unknown Journal|2025
0 cit.
8
Publication in Romanian Medical Journal (2025) [W7123784576]
Romanian Medical Journal|2025
0 cit.
9
Publication in Ecotoxicology and Environmental Safety (2026) [W7128433556]
Ecotoxicology and Environmental Safety|2026
0 cit.
10
Publication in Journal of Ethnopharmacology (2026) [W7134168140]
Journal of Ethnopharmacology|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nigora Srojidinova
Tashkent Pediatric Medical Institute
2
Sean P Turner
Wisconsin Elks Association
3
Yulius Patimang
Unknown
4
Haojun Chen
Wuhan University
5
Bailee Sliker
National Comprehensive Cancer Network
6
José Ángel López Jiménez
Hospital Universitari Germans Trias i Pujol
7
Matthew C. Bunte
Arrowhead Pharmaceuticals (United States)
8
Nikola Dobrilovic
Evanston Hospital
9
Amandeep Aneja
Cooper University Hospital
10
Sarah Chiang
Memorial Sloan Kettering Cancer Center

Papers

1
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
European Heart Journal - Cardiovascular Imaging|2022
491 cit.
2
Giant Left Atrial Myxoma Revealed by Neurological Manifestation in a Young Female Patient
International Journal of Innovative Science and Research Technology (IJISRT)|2024
242 cit.
3
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2024
167 cit.
4
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using<sup>68</sup>Ga-FAP-2286: Comparison with<sup>18</sup>F-FDG and<sup>68</sup>Ga-FAPI-46 in a Single-Center, Prospective Study
Journal of Nuclear Medicine|2022
110 cit.
5
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
Journal of Nuclear Medicine|2023
99 cit.
6
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study
Clinical Cancer Research|2023
93 cit.
7
<sup>68</sup>Ga Fibroblast Activation Protein Inhibitor PET/CT in the Detection of Metastatic Thyroid Cancer: Comparison with <sup>18</sup>F-FDG PET/CT
Radiology|2022
68 cit.
8
Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study
European Radiology|2022
64 cit.
9
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Signal Transduction and Targeted Therapy|2024
59 cit.
10
Clinical Evaluation of<sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub>in Various Cancer Types
Journal of Nuclear Medicine|2023
57 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Constantine A. Stratakis
Institute of Molecular Biology and Biotechnology
2
Christopher D.�M. Fletcher
Brigham and Women's Hospital
3
Sharon W. Weiss
Tel Aviv University
4
Cristina R. Antonescu
Memorial Sloan Kettering Cancer Center
5
Jean‐Yves Blay
Université Claude Bernard Lyon 1
6
Murray F. Brennan
Memorial Sloan Kettering Cancer Center
7
Renu Virmani
CVPath Institute
8
Andrew L. Folpe
Mayo Clinic in Arizona
9
Michael J. Reardon
Houston Methodist
10
Jérôme Bertherat
Centre National de la Recherche Scientifique

Papers

1
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
New England Journal of Medicine|2019
3.6k cit.
2
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
New England Journal of Medicine|2017
3k cit.
3
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
4
Pathology of Drug-Eluting Stents in Humans
Journal of the American College of Cardiology|2006
2.7k cit.
5
Two Hundred Gastrointestinal Stromal Tumors
Annals of Surgery|2000
2.5k cit.
6
Pathology of the Vulnerable Plaque
Journal of the American College of Cardiology|2006
2.3k cit.
7
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2018
1.6k cit.
8
Malignant fibrous histiocytoma.An Analysis of 200 Cases
Cancer|1978
1.5k cit.
9
Intraplaque Hemorrhage and Progression of Coronary Atheroma
New England Journal of Medicine|2003
1.5k cit.
10
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent
Circulation|2004
1.5k cit.

Reagents for Cardiac tumors and thrombi

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Histone H3 Antibody (ChIP Formulated)

#2650$314
View Evidence →
Cell Signaling TechnologyEvidence 65

IRS-2 Antibody

#4502$136,317
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-Chk2 (Thr68) (C13C1) Rabbit Monoclonal Antibody

#2197$169,411
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

AhR (D5S6H) Rabbit Monoclonal Antibody

#83200$173,351
View Evidence →
Cell Signaling Technology

TRBP2 (D7C8K) Rabbit Monoclonal Antibody

#62043$161,351
View Evidence →
Cell Signaling TechnologyEvidence 60

PathScan® Phospho-MEK1 (Ser217/221) Sandwich ELISA Kit

#7175$66,129,740
View Evidence →